tiprankstipranks
Ascentage Pharma Group International Unsponsored ADR (AAPG)
NASDAQ:AAPG
US Market
AAPG
Ascentage Pharma Group International Unsponsored ADR
RESEARCH TOOLSreports

Ascentage Pharma Group International Unsponsored ADR (AAPG) Income Statement

23 Followers

Ascentage Pharma Group International Unsponsored ADR Income Statement

Last quarter (Q2 2025), Ascentage Pharma Group International Unsponsored ADR's total revenue was ¥233.70M, an increase of 63.77% from the same quarter last year. In Q2, Ascentage Pharma Group International Unsponsored ADR's net income was ¥-590.77M. See Ascentage Pharma Group International Unsponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 980.65M¥ 221.98M¥ 209.71M¥ 27.91M¥ 12.45M
Gross Profit
¥ 951.57M¥ 191.44M¥ 187.71M¥ 24.58M¥ 10.48M
Operating Expenses
¥ 1.32B¥ 1.06B¥ 1.04B¥ 894.42M¥ 674.42M
Depreciation and Amortization
¥ 93.17M¥ 93.19M¥ 47.42M¥ 17.18M¥ 16.96M
EBITDA
¥ -237.63M¥ -743.61M¥ -786.97M¥ -798.34M¥ -652.23M
Operating Income
¥ -369.73M¥ -872.64M¥ -849.81M¥ -869.84M¥ -663.94M
Other Income/Expenses
¥ -25.52M¥ -60.23M¥ -37.36M¥ 37.59M¥ -11.51M
Pretax Income
¥ -395.25M¥ -932.86M¥ -887.17M¥ -832.25M¥ -675.45M
Net Income
¥ -405.43M¥ -925.64M¥ -882.92M¥ -782.42M¥ -677.61M
Per Share Metrics
Basic EPS
¥ -5.36¥ -52.48¥ -53.60¥ -49.12¥ -50.24
Diluted EPS
¥ -5.36¥ -52.48¥ -53.60¥ -49.12¥ -50.24
Weighted Average Shares Outstanding
 75.52M 17.64M 16.48M 15.91M 13.49M
Weighted Average Shares Outstanding (Diluted)
 75.52M 17.64M 16.48M 15.91M 13.49M
Currency in CNY

Ascentage Pharma Group International Unsponsored ADR Earnings and Revenue History